Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
437914
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
||
|
FDA ORPHAN DRUG |
438014
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3F0FR4W3H8
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY | |||
|
C101524
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY | |||
|
1514889-12-3
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY | |||
|
DB12413
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY | |||
|
10033
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY | |||
|
Indusatumab vedotin
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY | |||
|
300000025303
Created by
admin on Mon Mar 31 23:17:22 GMT 2025 , Edited by admin on Mon Mar 31 23:17:22 GMT 2025
|
PRIMARY |
ACTIVE MOIETY